CoreCap Advisors’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TSC
VFP
GI
VCM
FFA
GBT
EWP
PS
CoreCap Advisors's ABVX Position: Q3 2026 in Review
CoreCap Advisors reduced its Abivax (ABVX) stake by 48% in Q3 2026, selling an estimated $11K and leaving 100 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.
CoreCap Advisors first reported a position in ABVX in Q1 2026 and has held it in 3 quarters since. The position peaked at $25.5K in Q2 2026. 9 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- CoreCap Advisors held 100 shares of Abivax worth $9.9K as of Q3 2026.
- CoreCap Advisors sold 91 Abivax shares in Q3 2026, an estimated $11K.
- Abivax made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2056 holding.
- CoreCap Advisors first reported a position in Abivax in Q1 2026 and has held it in 3 quarters since.
- CoreCap Advisors's Abivax position peaked at $25.5K in Q2 2026.
- 9 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.